---
title: "Cordis announces positive 24-month results from Selution SFA Japan trial"
date: "2024-06-19T15:36:02.000Z"
publishedDate: "19 juin 2024"
summary: "Cordis has announced positive 24-month results from the Selution SFA Japan trial. The prospective, multicentre, single-arm trial is designed to assess the safety and efficacy of the Selution SLR drug-eluting balloon (DEB) for the endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and the popliteal artery (PA)."
importance: ""
sourceUrl: "https://vascularnews.com/cordis-announce-positive-24-month-results-from-selution-sfa-japan-trial/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-06-19-cordis-announces-positive-24-month-results-from-selution-sfa-japan-trial"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/06/Selution-SLR_Balloon-Arc-shape-with-logo.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/cordis-announce-positive-24-month-results-from-selution-sfa-japan-trial/"
---

![Cordis announces positive 24-month results from Selution SFA Japan trial](https://vascularnews.com/wp-content/uploads/sites/7/2024/06/Selution-SLR_Balloon-Arc-shape-with-logo.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/cordis-announce-positive-24-month-results-from-selution-sfa-japan-trial/*

## L’essentiel

Cordis has announced positive 24-month results from the Selution SFA Japan trial. The prospective, multicentre, single-arm trial is designed to assess the safety and efficacy of the Selution SLR drug-eluting balloon (DEB) for the endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and the popliteal artery (PA).

## Lien source

https://vascularnews.com/cordis-announce-positive-24-month-results-from-selution-sfa-japan-trial/
